Search

everythinglearnresearchcommunity

for

Search:↓

17α-estradiol is a safe estrogen that might protect the brain and doesn't cause feminization, needing more research for treating brain diseases.

ADSC-CE treatment safely increases hair density and thickness in androgenetic alopecia patients.

Intralesional therapy for keratoacanthoma is effective and has fewer side effects than systemic treatments.

An 81-year-old man's white hair began to regain its original color while he was treated with lenalidomide, suggesting that graying hair might be reversible.

Erlotinib can cause hair loss as a side effect.

Treg dysfunction is linked to various autoimmune skin diseases, and understanding Treg properties is key for new treatments.

Bendamustine combined with rituximab is an effective and well-tolerated treatment for certain types of lymphoma.

Non-viral vectors show promise for safe and effective CRISPR/Cas9 gene editing in treating diseases.

Liposomal anthracyclines are effective and safer for treating multiple myeloma, especially in elderly patients.

Finasteride treats enlarged prostate and baldness, but may cause limited urinary improvement and sex-related side effects.

Scientists have developed a new method to detect steroid abuse in athletes using cell-based tests, which could be the future of anti-doping methods.

Targeting EGFR may help reduce hair loss from chemotherapy.

Annurca apple extract may protect mouse hair from damage by chemotherapy and could help treat hair loss without promoting cancer growth.

Most treatments for spondyloarthritis are safe, but monitoring and careful selection based on patient risks are important.

Leucaena leucocephala is nutritious but needs careful processing to remove toxins.

EGFR inhibitors can cause various skin issues during cancer treatment, and managing these is important for patient care.

The article concludes that correctly diagnosing systemic causes of hair loss requires a detailed clinical evaluation and a systematic diagnostic approach.

Hurricane Sandy increased contamination in estuarine sediments in New Jersey and New York.

Ringworm around the eyes often gets misdiagnosed, leading to eyelash loss, but antifungal treatment can improve the condition.

EGFR cancer drugs often cause a rash, which can lead to distress and isolation, but may also improve outcomes for some cancer patients. Current treatments for the rash are limited, but a compound called menadione shows promise.

Melatonin-loaded nanocarriers improve melatonin delivery and effectiveness for various medical treatments.

Chitrak is a medicinal plant with health benefits like fighting microbes, reducing inflammation, and promoting hair growth, but it can be toxic and needs more research.

Allethrin caused harmful effects and organ damage in rats, worsening with higher doses and longer exposure.

The article concludes that hair loss is a common side effect of drugs treating skin cancer by blocking the hedgehog pathway, but treatment should continue, and more selective drugs might prevent this side effect.

EGFR inhibitors can cause yellowish skin eruptions.

Most children with CNS tumors on targeted therapy had skin reactions, which were generally treatable without stopping the therapy.

Sorafenib after liver surgery may increase survival for some liver cancer patients.

A cancer drug called nilotinib might cause hair loss due to inflammation around hair follicles.

Young female Australian fur seals are losing hair due to low tyrosine and zinc levels and high pollution exposure.

Blocking enzymes that help the virus enter cells could be a promising way to treat COVID-19.